HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA March 19 hearing in Senate Labor Cmte. likely to include reform, budget issues.

This article was originally published in The Rose Sheet

Executive Summary

FDA "RESTRUCTURING" HEARING IN SENATE LABOR CMTE. SET FOR MARCH 19, when the Senate begins its formal consideration of FDA-related issues, including proposals to revise and restructure the operations of the agency. Although an agenda is still in the planning stage, the committee has indicated that the March hearing is likely to focus on FDA reform, reauthorization of the Prescription Drug User Fee Act (PDUFA), other user fees and FDA resources. The hearing will take place in Dirksen Senate Office Building, room SD-430, starting at 9:30 a.m.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003879

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel